4.7 Article

The psoriasis-associated D10N variant of the adaptor Act1 with impaired regulation by the molecular chaperone hsp90

期刊

NATURE IMMUNOLOGY
卷 14, 期 1, 页码 72-81

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/ni.2479

关键词

-

资金

  1. US National Institutes of Health [1R01NS071996, 1P01 HL103453]
  2. Case Western Reserve University Medical Scientist Training Program [T32 GM007250]
  3. Case Western Reserve University Immunology Training Program [T32 AI 89474-1]
  4. American Asthma Foundation

向作者/读者索取更多资源

Act1 is an essential adaptor in interleukin 17 (IL-17)-mediated signaling and is recruited to the receptor for IL-17 after stimulation with IL-17. Here we found that Act1 was a 'client' protein of the molecular chaperone hsp90. The D10N variant of Act1 (Act1(D10N)) that is linked to susceptibility to psoriasis was defective in its interaction with hsp90, which resulted in a global loss of Act1 function. Act1-deficient mice modeled the mechanistic link between loss of Act1 function and susceptibility to psoriasis. Although Act1 was necessary for IL-17-mediated inflammation, Act1-deficient mice had a hyperactive response of the T(H)17 subset of helper T cells and developed spontaneous IL-22-dependent skin inflammation. In the absence of IL-17 signaling, IL-22 was the main contributor to skin inflammation, which provides a molecular mechanism for the association of Act1(D10N) with psoriasis susceptibility.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

RNF186 regulates EFNB1 (ephrin B1)-EPHB2-induced autophagy in the colonic epithelial cells for the maintenance of intestinal homeostasis

Huazhi Zhang, Zhihui Cui, Du Cheng, Yanyun Du, Xiaoli Guo, Ru Gao, Jianwen Chen, Wanwei Sun, Ruirui He, Xiaojian Ma, Qianwen Peng, Bradley N. Martin, Wei Yan, Yueguang Rong, Chenhui Wang

Summary: The gene RNF186 has been identified in genome-wide association studies as a susceptibility gene for ulcerative colitis, and it plays a crucial role in autophagy activation in colonic epithelial cells and intestinal homeostasis by regulating the ubiquitination of EPHB2. The absence of RNF186 and EPHB2 leads to a more severe phenotype in a colitis model, while treatment with ephrin-B1-Fc recombinant protein shows promise as a potential therapy for inflammatory bowel diseases.

AUTOPHAGY (2021)

Article Immunology

Cutting Edge: EPHB2 Is a Coreceptor for Fungal Recognition and Phosphorylation of Syk in the Dectin-1 Signaling Pathway

Wanwei Sun, Heping Wang, Huijun Hu, Xiaojian Ma, Huazhi Zhang, Jianwen Chen, Yanyun Du, Ruirui He, Zhihui Cui, Qianwen Peng, Chenhui Wang

Summary: This study demonstrates that EPHB2 acts as a coreceptor for Dectin-1 ligand recognition and plays an essential role in antifungal immunity by phosphorylating Syk.

JOURNAL OF IMMUNOLOGY (2021)

Article Immunology

Identification of a Long Noncoding RNA TRAF3IP2-AS1 as Key Regulator of IL-17 Signaling through the SRSF10-IRF1-Act1 Axis in Autoimmune Diseases

Ruirui He, Songfang Wu, Ru Gao, Jianwen Chen, Qianwen Peng, Huijun Hu, Liwen Zhu, Yanyun Du, Wanwei Sun, Xiaojian Ma, Huazhi Zhang, Zhihui Cui, Heping Wang, Bradley N. Martin, Yueying Wang, Cun-Jin Zhang, Chenhui Wang

Summary: The study showed that TRAF3IP2-AS1 regulates IL-17A signaling by recruiting SRSF10, indicating a therapeutic potential for IL-17-related autoimmune diseases.

JOURNAL OF IMMUNOLOGY (2021)

Article Microbiology

A swine arterivirus deubiquitinase stabilizes two major envelope proteins and promotes production of viral progeny

Rui Guo, Xingyu Yan, Yanhua Li, Jin Cui, Saurav Misra, Andrew E. Firth, Eric J. Snijder, Ying Fang

Summary: This study demonstrates that PRRSV nsp2TF interacts with the major arteriviral envelope proteins GP5 and M, promoting arterivirus assembly by antagonizing ubiquitination-dependent proteasomal degradation of these key viral structural proteins.

PLOS PATHOGENS (2021)

Article Multidisciplinary Sciences

MYO1F regulates antifungal immunity by regulating acetylation of microtubules

Wanwei Sun, Xiaojian Ma, Heping Wang, Yanyun Du, Jianwen Chen, Huijun Hu, Ru Gao, Ruirui He, Qianwen Peng, Zhihui Cui, Huazhi Zhang, Junhan Wang, Xinming Jia, Bradley N. Martin, Cun-Jin Zhang, Xiaoxia Li, Chenhui Wang

Summary: Opportunistic fungal infections are a leading cause of death among immunocompromised patients, with MYO1F playing a key role in promoting antifungal immunity by regulating alpha-tubulin acetylation. Sirt2 deacetylase inhibitors show potential as drugs for the treatment of fungal infections, increasing the expression of proinflammatory genes and providing protection against Candida albicans infections.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Immunology

DOCK2 regulates antifungal immunity by regulating RAC GTPase activity

Xiaojian Ma, Xi Tan, Bingbing Yu, Wanwei Sun, Heping Wang, Huijun Hu, Yanyun Du, Ruirui He, Ru Gao, Qianwen Peng, Zhihui Cui, Ting Pan, Xiong Feng, Junhan Wang, Chengqi Xu, Bin Zhu, Wei Liu, Chenhui Wang

Summary: Fungal infections cause millions of deaths each year and the mortality rate of disseminated candidiasis exceeds that of breast cancer and malaria. This study reveals the critical role of DOCK2 in promoting antifungal immune response and inflammation. DOCK2-deficient macrophages show reduced ability to kill intracellular fungi and activate downstream signaling pathways. Furthermore, nanoparticle-mediated delivery of IVT Rac1 mRNA enhances Rac1 activity and helps eliminate fungal infections in vivo.

CELLULAR & MOLECULAR IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Cancer cell-expressed BTNL2 facilitates tumour immune escape via engagement with IL-17A-producing γδ T cells

Yanyun Du, Qianwen Peng, Du Cheng, Ting Pan, Wanwei Sun, Heping Wang, Xiaojian Ma, Ruirui He, Huazhi Zhang, Zhihui Cui, Xiong Feng, Zhiqiang Liu, Tianxin Zhao, Wenjun Hu, Lei Shen, Wenyang Jiang, Na Gao, Bradley N. Martin, Cun-Jin Zhang, Zhanguo Zhang, Chenhui Wang

Summary: This study reveals that BTNL2 is a potent suppressor of anti-tumor immune response. Blockade of BTNL2 attenuates tumor progression and prolongs survival in tumor-bearing mice. BTNL2 interacts with γ δ T cell populations to promote IL-17A production, leading to a dysfunctional tumor immune microenvironment. High BTNL2 expression is associated with tumor types and negatively correlates with patient survival.

NATURE COMMUNICATIONS (2022)

Article Oncology

Oncolytic Zika virus promotes intratumoral T cell infiltration and improves immunotherapy efficacy in glioblastoma

Lishu Chen, Chao Zhou, Qi Chen, Jingzhe Shang, Zhaodan Liu, Yan Guo, Chunfeng Li, HongJiang Wang, Qing Ye, XiaoFeng Li, Shulong Zu, Fangye Li, Qing Xia, Tao Zhou, Ailing Li, Chenhui Wang, Yun Chen, Aiping Wu, Chengfeng Qin, Jianghong Man

Summary: Zika virus treatment can enhance immune cell infiltration and activation in glioblastoma and inhibit tumor growth. Additionally, Zika virus can activate the interferon signaling pathway in glioblastoma cells. This therapy can improve the sensitivity of glioblastoma to immune checkpoint blockade.

MOLECULAR THERAPY-ONCOLYTICS (2022)

Article Biochemistry & Molecular Biology

BTNL2 promotes colitis-associated tumorigenesis in mice by regulating IL-22 production

Qianwen Peng, Ting Pan, Ruirui He, Ming Yi, Lingyun Feng, Zhihui Cui, Ru Gao, Heping Wang, Xiong Feng, Hui Li, Yuan Wang, Cun-jin Zhang, Du Cheng, Yanyun Du, Chenhui Wang

Summary: This study reveals that BTNL2 is necessary for colorectal IL-22 production and its knockout leads to decreased colonic tumorigenesis and more severe colitis phenotypes. BTNL2 acts on ILC3s, CD4(+) T cells, and gamma delta T cells to promote IL-22 production. Importantly, a monoclonal antibody against BTNL2 attenuates colorectal tumorigenesis in mice and mBTNL2-Fc recombinant protein shows therapeutic effect in a colitis model. This study not only identifies a regulatory mechanism of IL-22 production in the colorectal system, but also provides a potential therapeutic target for human colorectal cancer and inflammatory bowel diseases.

EMBO REPORTS (2023)

Article Microbiology

T-cell activation Rho GTPase-activating protein maintains intestinal homeostasis by regulating intestinal T helper cells differentiation through the gut microbiota

Ruirui He, Jianwen Chen, Ziyan Zhao, Changping Shi, Yanyun Du, Ming Yi, Lingyun Feng, Qianwen Peng, Zhihui Cui, Ru Gao, Heping Wang, Yi Huang, Zhi Liu, Chenhui Wang

Summary: Recent research has found that common variants of the T-cell activation Rho GTPase-activating protein (TAGAP) are associated with susceptibility to inflammatory bowel diseases (IBDs) in humans, but the underlying mechanisms are still unclear. This study showed that TAGAP deficiency or downregulation of TAGAP expression caused by TAGAP gene polymorphism leads to decreased production of antimicrobial peptides (AMPs), such as reg3g, which in turn disrupts the gut microbiota, including Akkermansia muciniphila and Bacteroides acidifaciens strains. These strains can polarize T helper cell differentiation in the gut and exacerbate the phenotype of dextran sodium sulfate-induced disease in mice. Importantly, the study demonstrated that recombinant reg3g protein or anti-p40 monoclonal antibody had therapeutic effects in the treatment of dextran sodium sulfate-induced colitis, suggesting their potential as medicines for human IBD treatment, especially for patients carrying the common variant of TAGAP rs212388.

FRONTIERS IN MICROBIOLOGY (2023)

Article Immunology

Identification of a Small Molecule with Strong Anti-Inflammatory Activity in Experimental Autoimmune Encephalomyelitis and Sepsis through Blocking Gasdermin D Activation

Runjing Cao, Zihao Li, Chuyu Wu, Senlin Ji, Yahui Li, Xiang Cao, Xiaohong Dong, Meiling Jiang, Tao Pang, Chenhui Wang, Jingwei Li, Yun Xu, Cun-Jin Zhang

Summary: Pyroptosis is a key inflammatory form of cell death that plays an important role in the progression of many inflammatory diseases. In this study, we conducted a screening of compounds based on in silico docking and found that C202-2729 could significantly attenuate the severity of experimental autoimmune encephalomyelitis (EAE) and showed comparable effects to the clinical drug teriflunomide. Furthermore, we found that C202-2729 did not affect GSDMD cleavage, upstream inflammasome activation, pore formation, and mature IL-1b release in mouse macrophages. These findings suggest that C202-2729 may have potential for translational application in GSDMD-associated inflammatory diseases.

JOURNAL OF IMMUNOLOGY (2022)

暂无数据